Previous research revealed that being overweight or obese is a risk factor for various forms of cancer. It is also known that obese women are more likely to develop cancer than their male counterparts, and the risk level reduces with intentional weight loss. However, there is limited evidenc
Higher levels of inflammation in the blood of obese patients undergoing bariatric surgery predict poorer weight loss six months later, according to a study funded by the National Institute of Health and Care Research (NIHR).
Higher levels of inflammation in the blood of obese patients after bariatric surgery have been proven to indicate less successful weight loss six months after the operation, according to research supported by the National Institute for Health and Care Research (NIHR).
The National Institute for Health and Care Research (NIHR)-funded study found that higher levels of inflammation in the blood of obese patients undergoing bariatric surgery predict poorer weight loss six months later.
Bariatric surgery is associated with lower all-cancer and obesity-related cancer incidence among females, according to recent research that took into account follow-up years, increased sample sizes, and numerous surgical procedures.
According to a new study published in Obesity, the flagshi
According to a new study presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting, bariatric surgery, also known as weight-loss or metabolic surgery, was associated with a 42% lower risk of major adverse cardiovascular events (MACE) such as
Mumbai (Maharashtra) [India], June 22: To help people understand the importance of maintaining an optimum weight to lead a healthy life, Laparo Obeso Centre organized an obesity support group meeting in Mumbai where more than 100 patients had been participated and open up their weightless jo
A study found that later body contouring to remove extra skin is not by itself related to long-term weight loss for individuals who underwent bariatric surgery and lost a significant amount of weight.
According to a study to be presented at Digestive Disease Week (DDW) 2023, just 4% of patients with obesity who underwent bariatric surgery developed obesity-associated cancer in a 10-year follow-up, compared to 8.9% of those who did not have a weight-loss treatment.
A study has revealed that metabolic (bariatric) surgery is more effective than medications for the treatment of advanced non-alcoholic fatty liver disease.
A study has found that metabolic (bariatric) surgery is more effective than medications for the treatment of advanced non-alcoholic fatty liver disease.
A research team led by the University of Michigan Health Department of Neurology followed more than 120 patients who underwent bariatric surgery for obesity over two years after the procedure. They found that all metabolic risk factors for developing diabetes, such as high glucose and lipid